Armata Pharmaceuticals Stock Market Value
| ARMP Stock | USD 8.24 0.24 3.00% |
| Symbol | Armata |
Can Biotechnology industry sustain growth momentum? Does Armata have expansion opportunities? Factors like these will boost the valuation of Armata Pharmaceuticals. If investors know Armata will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Armata Pharmaceuticals demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.66) | Revenue Per Share | Quarterly Revenue Growth (0.61) | Return On Assets | Return On Equity |
Armata Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Armata's balance sheet. Smart investors calculate Armata Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Armata Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Armata Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Armata Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Armata Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Armata Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Armata Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Armata Pharmaceuticals.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Armata Pharmaceuticals on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Armata Pharmaceuticals or generate 0.0% return on investment in Armata Pharmaceuticals over 90 days. Armata Pharmaceuticals is related to or competes with Sangamo Therapeutics, Insight Molecular, C4 Therapeutics, Codexis, OmniAb, Nuvectis Pharma, and NeOnc Technologies. Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriopha... More
Armata Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Armata Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Armata Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.55 | |||
| Information Ratio | 0.0996 | |||
| Maximum Drawdown | 36.3 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 14.07 |
Armata Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Armata Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Armata Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Armata Pharmaceuticals historical prices to predict the future Armata Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.099 | |||
| Jensen Alpha | 0.6934 | |||
| Total Risk Alpha | 0.1586 | |||
| Sortino Ratio | 0.107 | |||
| Treynor Ratio | 0.7003 |
Armata Pharmaceuticals February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.099 | |||
| Market Risk Adjusted Performance | 0.7103 | |||
| Mean Deviation | 5.19 | |||
| Semi Deviation | 6.08 | |||
| Downside Deviation | 6.55 | |||
| Coefficient Of Variation | 900.29 | |||
| Standard Deviation | 7.03 | |||
| Variance | 49.48 | |||
| Information Ratio | 0.0996 | |||
| Jensen Alpha | 0.6934 | |||
| Total Risk Alpha | 0.1586 | |||
| Sortino Ratio | 0.107 | |||
| Treynor Ratio | 0.7003 | |||
| Maximum Drawdown | 36.3 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 14.07 | |||
| Downside Variance | 42.9 | |||
| Semi Variance | 36.91 | |||
| Expected Short fall | (5.64) | |||
| Skewness | 0.1158 | |||
| Kurtosis | 1.1 |
Armata Pharmaceuticals Backtested Returns
Armata Pharmaceuticals appears to be moderately volatile, given 3 months investment horizon. Armata Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0621, which signifies that the company had a 0.0621 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Armata Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Armata Pharmaceuticals' Risk Adjusted Performance of 0.099, downside deviation of 6.55, and Mean Deviation of 5.19 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Armata Pharmaceuticals holds a performance score of 4. The firm shows a Beta (market volatility) of 1.1, which signifies a somewhat significant risk relative to the market. Armata Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Armata Pharmaceuticals is expected to follow. Please check Armata Pharmaceuticals' downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Armata Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.14 |
Insignificant predictability
Armata Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Armata Pharmaceuticals time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Armata Pharmaceuticals price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Armata Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.56 |
Pair Trading with Armata Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Armata Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Armata Stock
| 0.5 | QSI | QuantumSi | PairCorr |
| 0.49 | LYRA | Lyra Therapeutics | PairCorr |
| 0.45 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
| 0.42 | ABP | Abpro Holdings | PairCorr |
| 0.38 | KURA | Kura Oncology | PairCorr |
The ability to find closely correlated positions to Armata Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Armata Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Armata Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Armata Pharmaceuticals to buy it.
The correlation of Armata Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Armata Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Armata Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Armata Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Armata Stock Analysis
When running Armata Pharmaceuticals' price analysis, check to measure Armata Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Armata Pharmaceuticals is operating at the current time. Most of Armata Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Armata Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Armata Pharmaceuticals' price. Additionally, you may evaluate how the addition of Armata Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.